Condition: Lung Cancer Diagnosis · Sponsor: Freenome Holdings Inc.
The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT).
This description comes directly from the study's public registry record.
Harris Naemi, BS · 925-322-6486 · FRNM007@freenome.com
Always discuss trial participation with your own doctor first.
| Science 37 | Los Angeles, California, United States | Recruiting |
| Stamford Hospital | Stamford, Connecticut, United States | Recruiting |
| Hillcrest Medical Research | DeLand, Florida, United States | Recruiting |
| Universal Axon Clinical Research | Doral, Florida, United States | Recruiting |
| I.H.S Health, LLC | Kissimmee, Florida, United States | Recruiting |
| United Medical Research | Port Orange, Florida, United States | Recruiting |
| Charter Research | The Villages, Florida, United States | Recruiting |
| Charter Research | Winter Park, Florida, United States | Recruiting |
| SpeciCare, Inc | Gainesville, Georgia, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Walgreens | Deerfield, Illinois, United States | Recruiting |
| Springfield Clinic, LLP | Springfield, Illinois, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06122077